South Korea grants approval to Novavax Covid-19 vaccine
South Korea’s MFDS granted approval to a BLA from SK bioscience for Novavax’s recombinant, adjuvanted Covid-19 vaccine, Nuvaxovid.
Source: pharmaceutical-technology.com
Stay updated with breaking news from Preference Management Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
South Korea’s MFDS granted approval to a BLA from SK bioscience for Novavax’s recombinant, adjuvanted Covid-19 vaccine, Nuvaxovid.
The global Covid death toll has passed the grime milestone of 5.5 million, with a figure of 5,504,291 according to Johns Hopkins University.